Trial Profile

Improving Transplant Opportunities for Patients who are Sensitised (ITOPS) - a feasibility, randomised, controlled phase III trial

Status: Suspended

Phase of Trial: Phase III

Latest Information Update: 09 Feb 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bortezomib (Primary) ; Dexamethasone (Primary) ; Rituximab (Primary)
Indications Renal transplant rejection
Focus Therapeutic Use
Acronyms ITOPS

Most Recent Events

18 Jul 2022 Planned End Date changed from 1 Sep 2021 to 1 Apr 2022.
23 Apr 2020 Status changed from recruiting to suspended.
04 Oct 2019 Status changed to recruiting.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com